Keywords: review, second, qtr, implications, euro, firms, major

Review Of US Second Qtr & Implications For Euro Firms

Article | 20 August 1998

Print This

As the major US pharmaceutical companies conclude reporting theirresults for the second quarter of 1998, analysts at Goldman Sachs have been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in